Linda Karger
Chief Operating Officer & Co Founder Primogene
Linda Karger is COO and Co-Founder of Primogene GmbH, a company developing enzymatic bioprocesses for the production of human-identical ingredients. Primogene specifically focuses on the enzymatic production of complex human milk oligosaccharides (HMOs), including various LNFP structures, and has developed scalable bioprocesses for their manufacturing.
Seminars
Thursday 11th June 2026
Making Advanced HMOs Accessible: From Evolutionary Insight to Scalable, Affordable Production
12:00 pm
- Understand how human milk oligosaccharides (HMOs) and the infant microbiome evolved together, and why complex HMOs like the LNFP family and DSLNT play a critical role in early-life development
- Examine the current infant formula landscape to understand why high prices and technological barriers have prevented the widespread use of high-concentration HMOs
- Learn how Primogene utilizes safe and scalable technology to achieve commoditylevel pricing so all infants can have access to broad range of HMOs
- Explore how an enzyme-based manufacturing approach follows a regulatory-proven route, comparable to established GOS production processes
- Discover our proven manufacturing capabilities from gram to metric ton scales and explore partnership opportunities to bring these vital nutrients to the market
